Latest 10-K annual reports

iCAD, Inc. files an amendment to its 2024 annual report on Form 10-K to restate information regarding directors, executive compensation, security ownership, related transactions, and accounting fees, while also addressing certifications and the pending merger with RadNet.
NASDAQ
Adagio Medical Holdings files an amendment to its annual report to include information on directors, executive officers, corporate governance, and updated exhibits.
Regulus Therapeutics files an amendment to its annual report on Form 10-K to include information required in Part III, which was not initially included due to the delay in filing the definitive proxy statement.
AMEX
The Arena Group Holdings, Inc. files an amendment to its Form 10-K for the year ended December 31, 2024, to include previously omitted information regarding directors, executive officers, compensation, security ownership, related transactions, and principal accountant fees.
Rein Therapeutics files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
Generation Income Properties files an amendment to its 2024 annual report on Form 10-K to include previously omitted information and exhibits.
AMEX
Nuburu, Inc. files an amendment to its 2024 annual report, updating information on funding agreements, corporate governance, and a strategic shift following a foreclosure and subsequent asset diversification.
OTC.Pink
ProPhase Labs files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, principal accountant fees, and a subsequent event relating to executive salary deferrals.
NASDAQ
Power Solutions International files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
OTC.Pink
Marky Corp., a social media marketing information services provider, saw revenue growth but also a larger net loss in the fiscal year ending January 31, 2025, alongside a change in company control.
NASDAQ
Solidion Technology files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NYSE
Boston Omaha Corporation files an amendment to its 2024 Annual Report on Form 10-K to include information required in Part III regarding directors, executive officers, compensation, and related matters.
Complete Solaria reports a net loss of $56.5 million for fiscal year 2024 and identifies conditions raising substantial doubt about its ability to continue as a going concern.
OQB
SpringBig Holdings files an amendment to its 2024 Annual Report on Form 10-K, primarily to include Part III information regarding directors, executive officers, and corporate governance.
NASDAQ
TruGolf Holdings files an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive officers, and corporate governance.
Golden Matrix Group files an amendment to its 2024 Annual Report on Form 10-K to include required XBRL tagging and restate certain items.
NASDAQ
SHF Holdings files an amendment to its annual report on Form 10-K/A for the year ended December 31, 2024, to include previously omitted information and update the exhibit list.
NASDAQ
Intrusion Inc. files an amendment to its annual report on Form 10-K/A to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, director independence, principal accountant fees, and to correct a hyperlink.
OQB
International Isotopes Inc. filed an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NASDAQ
Tesla's Amendment No. 1 to its 2024 Annual Report on Form 10-K includes previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
Omeros Corporation files an amendment to its 2024 annual report to include information previously omitted regarding directors, executive compensation, security ownership, related transactions, and accounting fees.
OTC.Pink
HOOKIPA Pharma Inc. filed an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
LivePerson files an amendment to its 2024 Annual Report on Form 10-K/A to include information omitted from the original filing regarding directors, executive officers, and corporate governance.
NeuroMetrix, Inc. files an amendment to its annual report on Form 10-K to include required disclosures in Part III, Items 10, 11, 12, 13 and 14, and Item 15 of Part IV.
Spirit Aviation Holdings files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
FIEE, Inc. files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
NYSE
AMC Entertainment Holdings, Inc. files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, corporate governance, and exhibits.
NASDAQ
Mawson Infrastructure Group Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and exhibits.
Houston American Energy Corp. files an amendment to its 2024 annual report on Form 10-K/A to include previously omitted information and address administrative errors in executive certifications, while also disclosing material weaknesses in internal control over financial reporting.
NASDAQ
TherapeuticsMD files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.